Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Ultrasound Obstet Gynecol ; 63(3): 342-349, 2024 03.
Article in English | MEDLINE | ID: mdl-37698230

ABSTRACT

OBJECTIVES: To describe the distributional properties and assess the performance of placental growth factor (PlGF) measured in blood samples collected before 11 weeks' gestation in the prediction of pre-eclampsia (PE). METHODS: The study population consisted of pregnant women included in the Pre-eclampsia Screening in Denmark (PRESIDE) study with a PlGF measurement from the routine combined first-trimester screening (cFTS) blood sample collected at 8-14 weeks' gestation. PRESIDE was a prospective multicenter study investigating the predictive performance of the Fetal Medicine Foundation (FMF) first-trimester screening algorithm for PE in a Danish population. In the current study, serum concentration of PlGF in the cFTS blood samples was analyzed in batches between January and June 2021. RESULTS: A total of 8386 pregnant women were included. The incidence of PE was 0.7% at < 37 weeks' gestation and 3.0% at ≥ 37 weeks. In blood samples collected at 10 weeks' gestation, PlGF multiples of the median (MoM) were significantly lower in pregnancies with preterm PE < 37 weeks compared to unaffected pregnancies. However, PlGF MoM did not differ significantly between pregnancies with PE and unaffected pregnancies in samples collected before 10 weeks' gestation. CONCLUSIONS: The gestational-age range for PlGF sampling may be expanded from 11-14 to 10-14 weeks when assessing the risk for PE using the FMF first-trimester screening model. There is little evidence to support the use of PlGF in blood samples collected before 10 weeks' gestation. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


Subject(s)
Pre-Eclampsia , Pregnancy , Infant, Newborn , Humans , Female , Placenta Growth Factor , Pre-Eclampsia/diagnosis , Prospective Studies , Algorithms , Gestational Age
2.
Ultrasound Obstet Gynecol ; 61(6): 682-690, 2023 06.
Article in English | MEDLINE | ID: mdl-36840981

ABSTRACT

OBJECTIVES: To investigate the predictive performance of the Fetal Medicine Foundation (FMF) first-trimester screening algorithm for pre-eclampsia in a Danish population and compare screening performance with that of the current Danish strategy, which is based on maternal risk factors. METHODS: This was a prospective study of women with a singleton pregnancy attending for their first-trimester ultrasound scan and screening for aneuploidies at six Danish university hospitals between May 2019 and December 2020. Prenatal data on maternal characteristics and medical history were recorded, and measurements of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum pregnancy-associated plasma protein-A (PAPP-A) and serum placental growth factor (PlGF) were collected without performing a risk assessment for pre-eclampsia. Information on acetylsalicylic acid use was recorded. After delivery, pregnancy outcome, including gestational age at delivery and pre-eclampsia diagnosis, was recorded. Pre-eclampsia risk assessment for each woman was calculated blinded to outcome using the FMF screening algorithm following adjustment to the Danish population. Detection rates (DRs) of the FMF algorithm were calculated for a fixed screen-positive rate (SPR) of 10% and for the SPR achieved in the current Danish screening. RESULTS: A total of 8783 pregnant women were included, with a median age of 30.8 (interquartile range (IQR), 28.1-33.9) years. The majority were white (95%), naturally conceiving (90%), non-smokers (97%) and had no family history of pre-eclampsia (96%). The median body mass index was 23.4 (IQR, 21.2-26.6) kg/m2 . A complete risk assessment including maternal characteristics, MAP, UtA-PI, PlGF and PAPP-A was available for 8156 women (92.9%). In these women, UtA-PI was measured bilaterally with a median value of 1.58 (IQR, 1.27-1.94) and the median resting MAP of 80.5 (IQR, 76.1-85.4) mmHg in two consecutive measurements. Among these, 303 (3.7%) developed pre-eclampsia, including 55 (0.7%) cases of pre-eclampsia with delivery < 37 weeks of gestation and 16 (0.2%) cases of pre-eclampsia with delivery < 34 weeks. At a SPR of 10%, combined screening using the FMF algorithm based on maternal characteristics, MAP, UtA-PI, PlGF and PAPP-A had a DR of 77.4% (95% CI, 57.6-97.2%) for pre-eclampsia with delivery < 34 weeks, 66.8% (95% CI, 54.4-79.1%) for pre-eclampsia with delivery < 37 weeks and 44.1% (95% CI, 38.5-49.7%) for pre-eclampsia with delivery at any gestational age. The current Danish screening strategy using maternal risk factors detected 25.0% of women with pre-eclampsia with delivery < 34 weeks and 19.6% of women with pre-eclampsia with delivery < 37 weeks at a SPR of 3.4%. When applying the FMF algorithm including maternal characteristics, MAP, UtA-PI and PlGF at the fixed SPR of 3.4%, the DRs were 60.5% (95% CI, 36.9-84.1%) for PE with delivery < 34 weeks and 45.2% (95% CI, 32.0-58.5%) for PE with delivery < 37 weeks. CONCLUSION: In this large Danish multicenter study, the FMF algorithm based on maternal characteristics, MAP, UtA-PI, PlGF and PAPP-A predicted 77.4% of cases with pre-eclampsia with delivery < 34 weeks and 66.8% of cases with pre-eclampsia with delivery < 37 weeks of gestation at a SPR of 10%, suggesting that the performance of the algorithm in a Danish cohort matches that in other populations. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


Subject(s)
Pre-Eclampsia , Prenatal Diagnosis , Pregnancy , Female , Humans , Pre-Eclampsia/epidemiology , Prospective Studies , Pregnancy-Associated Plasma Protein-A , Placenta Growth Factor , Arterial Pressure , Uterine Artery/diagnostic imaging , Biomarkers , Pulsatile Flow , Denmark/epidemiology
3.
Osteoarthritis Cartilage ; 29(9): 1291-1295, 2021 09.
Article in English | MEDLINE | ID: mdl-34174456

ABSTRACT

OBJECTIVE: We evaluated whether patient-reported outcome trajectories (i.e., changes over time) differed by intraoperative compartmental cartilage lesion pattern over 4-6 years following arthroscopic meniscal surgery. METHODS: In this ancillary study of the Knee Arthroscopy Cohort Southern Denmark cohort, we intraoperatively categorized cartilage lesions as isolated patellofemoral, isolated tibiofemoral, or combined patellofemoral/tibiofemoral. Participants completed the Knee injury and Osteoarthritis Outcome Score (KOOS) pre-operatively, at 3 and 12 months, and at 4-6 years post-operatively and reported overall satisfaction at final follow-up. Our main outcome was KOOS4 (grand mean of four subscale means). We evaluated whether KOOS4 scores changed over time according to cartilage lesion patterns using adjusted mixed linear regression. We also estimated probability of treatment satisfaction using logistic regression. RESULTS: Of 630 participants with complete cartilage scores, 280 (44%) were women, mean (standard deviation) age was 49 (13) years, and BMI was 27.3 (4.4) kg/m2. KOOS4 scores at baseline were slightly lower in all lesion groups compared to the no lesion group, yet only the combined group was statistically significantly lower. KOOS4 trajectories were similar across cartilage lesion patterns, but by final follow-up, adjusted mean KOOS4 scores were 6.8 (95% CI 2.2, 11.4) to 9.8 (1.1, 18.5) points lower in groups with cartilage lesions compared to the no lesion group. Probability of patient-reported satisfaction did not differ statistically by group. CONCLUSIONS: Though KOOS4 scores were slightly lower in groups with arthroscopically assessed cartilage lesions compared to the no lesion group, trajectories were similar across all groups.


Subject(s)
Arthroscopy , Cartilage/pathology , Diagnostic Self Evaluation , Osteoarthritis, Knee/pathology , Patient Reported Outcome Measures , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Meniscus/surgery , Middle Aged , Patellofemoral Joint , Prospective Studies , Risk Assessment , Tibia , Time Factors
4.
Osteoarthritis Cartilage ; 29(1): 39-49, 2021 01.
Article in English | MEDLINE | ID: mdl-33220446

ABSTRACT

OBJECTIVE: To investigate if comorbidities are associated with change in health outcomes following an 8-week exercise and education program in knee and hip osteoarthritis (OA). METHODS: We included 24,513 individuals with knee or hip OA from the Good Life with osteoArthritis in Denmark (GLA:D®). GLA:D® consists of two patient education sessions and 12 supervised exercise sessions. Before the program, individuals self-reported having one or more of 11 common comorbidities. Physical function was assessed using the 40-m Fast-Paced Walk Test (FPWT, m/sec) before and immediately after the program. Pain intensity and health-related quality of life was self-reported before, immediately after, and at 12 months post-intervention using a visual analogue scale (VAS, 0-100) and the EQ-5D-5L index (-0.624 to 1.000), respectively. Associations of comorbidity combinations with change in outcomes immediately and at 12 months was estimated using mixed linear regression. RESULTS: Individuals with OA improved on average 0.12 m/s (95%CI 0.12 to 0.13) in 40-m FPWT, -12.7 mm (95%CI -13.2 to -12.2) in VAS, and 0.039 (95%CI 0.036 to 0.041) in EQ-5D-5L from before to immediately after the intervention with minor additional improvements at 12 months. Despite that individuals with comorbidities had worse baseline scores in all outcomes than individuals without comorbidities, they had similar levels of improvement immediately and 12 months after the intervention. CONCLUSION: Comorbidities are not associated with worse nor better health outcomes following an 8-week exercise and education program in individuals with OA, suggesting exercise as a viable treatment option for individuals with OA, irrespective of comorbidities.


Subject(s)
Exercise Therapy , Osteoarthritis, Hip/rehabilitation , Osteoarthritis, Knee/rehabilitation , Patient Education as Topic , Aged , Anemia/epidemiology , Arthritis, Rheumatoid/epidemiology , Cohort Studies , Comorbidity , Depressive Disorder/epidemiology , Diabetes Mellitus/epidemiology , Female , Gastrointestinal Diseases/epidemiology , Heart Diseases/epidemiology , Humans , Hypertension/epidemiology , Kidney Diseases/epidemiology , Liver Diseases/epidemiology , Male , Middle Aged , Neoplasms/epidemiology , Nervous System Diseases/epidemiology , Osteoarthritis, Hip/epidemiology , Osteoarthritis, Hip/physiopathology , Osteoarthritis, Knee/epidemiology , Osteoarthritis, Knee/physiopathology , Pain Measurement , Physical Functional Performance , Quality of Life , Respiratory Tract Diseases/epidemiology , Treatment Outcome , Walking Speed
5.
Osteoarthritis Cartilage ; 26(8): 1008-1016, 2018 08.
Article in English | MEDLINE | ID: mdl-29792925

ABSTRACT

OBJECTIVE: Patients with degenerative or traumatic meniscal tears are at high risk of developing knee osteoarthritis. We investigated if younger (≤40 years) and older (>40 years) patients with preoperative mechanical symptoms (MS) improved more in patient-reported outcomes after meniscal surgery than those without MS. DESIGN: Patients from Knee Arthroscopy Cohort Southern Denmark (KACS) undergoing arthroscopic surgery for a meniscal tear completed online questionnaires before surgery, and at 12 and 52 weeks follow-up. Questionnaires included self-reported presence of MS (i.e., sensation of catching and/or locking) and the Knee injury and Osteoarthritis Outcome Score (KOOS). We analyzed between-group differences in change in KOOS4 from baseline to 52 weeks, using an adjusted mixed linear model. RESULTS: 150 younger patients (mean age 31 (SD 7), 67% men) and 491 older patients (mean age 54 (SD 9), 53% men) constituted the baseline cohorts. Patients with MS generally had worse self-reported outcomes before surgery. At 52 weeks follow-up, younger patients with preoperative MS had improved more in KOOS4 scores than younger patients without preoperative MS (adjusted mean difference 10.5, 95% CI: 4.3, 16.6), but did not exceed the absolute postoperative KOOS4 scores observed for those without MS. No difference in improvement was observed between older patients with or without MS (adjusted mean difference 0.7, 95% CI: -2.6, 3.9). CONCLUSIONS: Younger patients (≤40 years) with preoperative MS experienced greater improvements after arthroscopic surgery compared to younger patients without MS. Our observational study result needs to be confirmed in randomized trials.


Subject(s)
Arthroscopy , Knee Injuries/surgery , Meniscus/injuries , Adult , Female , Humans , Knee Injuries/pathology , Male , Meniscus/pathology , Meniscus/surgery , Middle Aged , Patient Reported Outcome Measures , Prospective Studies
6.
AAPS J ; 16(3): 504-15, 2014 May.
Article in English | MEDLINE | ID: mdl-24687208

ABSTRACT

The L4 Global Harmonization Team on reagents and their stability focused on the management of critical reagents for pharmacokinetic, immunogenicity, and biomarker ligand binding assays. Regulatory guidance recognizes that reagents are important for ligand binding assays but do not address numerous aspects of critical reagent life cycle management. Reagents can be obtained from external vendors or developed internally, but regardless of their source, there are numerous considerations for their reliable long-term use. The authors have identified current best practices and provided recommendations for critical reagent lot changes, stability management, and documentation.


Subject(s)
Indicators and Reagents/chemistry , Indicators and Reagents/standards , Ligands , Biomarkers , Documentation , Humans , Indicators and Reagents/supply & distribution , Pharmacokinetics , Reference Standards
7.
Acta Obstet Gynecol Scand ; 69(5): 433-5, 1990.
Article in English | MEDLINE | ID: mdl-1702921

ABSTRACT

Choriocarcinoma is a rare malignancy in Scandinavia. We present a case of a young primigravida who experienced an uneventful pregnancy and gave birth to a healthy baby. Six days after delivery she underwent neurosurgery for intracranial hemorrhage. Pathological examination of the evacuated hematoma revealed metastatic choriocarcinoma. Further work-up exposed additional metastases in the lungs and liver. The initial serum level of human chorionic gonadotropin (beta-HCG) was 350,000 IU/I. Chemotherapy was given both intravenously and intrathecally. At 10 weeks, beta-HCG had returned to normal. Treatment was continued for another 10 weeks. Two years after cessation of therapy the patient is still in complete remission. In the discussion we review a scoring system to be used in selecting the mode of treatment, and briefly mention diagnosis and prognosis.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols , Brain Neoplasms/secondary , Choriocarcinoma/secondary , Uterine Neoplasms/epidemiology , Adult , Choriocarcinoma/drug therapy , Choriocarcinoma/epidemiology , Chorionic Gonadotropin/blood , Chorionic Gonadotropin, beta Subunit, Human , Cyclophosphamide/administration & dosage , Dactinomycin/administration & dosage , Female , Humans , Leucovorin/administration & dosage , Methotrexate/administration & dosage , Peptide Fragments/blood , Pregnancy , Sweden/epidemiology , Uterine Neoplasms/drug therapy , Uterine Neoplasms/pathology
8.
Acta Physiol Scand ; 125(3): 423-7, 1985 Nov.
Article in English | MEDLINE | ID: mdl-3909741

ABSTRACT

Bovine chromaffin granules were shown to contain two potent proteolytic systems resulting in limited proteolysis of granule proteins at pH 6.0 in the cold in the presence of inhibitors of serine and thiol proteases. Calcium, whether added during lysis or remaining bound to the lysate protein during dialysis in non-chelating solutions, enhanced recoveries of total immunoreactive dopamine beta-hydroxylase (14% of total protein) and soluble enzyme (9% of lysate protein) due to degradation of of chromogranins. A pepstatin A-blockable, catepsin D-like proteolytic system converting membrane-bound enzyme to its soluble counterpart at pH 6.0 was detected in the granule membrane fraction.


Subject(s)
Adrenal Medulla/enzymology , Calcium/pharmacology , Chromaffin Granules/enzymology , Chromaffin System/enzymology , Dopamine beta-Hydroxylase/metabolism , Peptide Hydrolases/metabolism , Adrenal Medulla/drug effects , Animals , Catecholamines/metabolism , Cathepsin D/pharmacology , Cattle , Cell Membrane/enzymology , Chromaffin Granules/drug effects , In Vitro Techniques , Pepstatins/pharmacology
9.
Acta Physiol Scand ; 123(1): 21-33, 1985 Jan.
Article in English | MEDLINE | ID: mdl-3969832

ABSTRACT

The soluble proteins (chromogranins) of bovine chromaffin granules have been studied by micro-osmometry with semi-permeable membranes (UM2, PM10 and PM30 with cut-offs greater than 1, greater than 10 and greater than 30 kD, respectively) at 1 = 0.15 and pH 5-8 for protein concentrations up to 20 mg X ml-1. After lysis of chromaffin granules in phosphate buffer pH 6, the released chromogranins behaved as aggregating solutes, consistent with an inconspicuous osmotic pressure contribution from the chromogranins at the protein concentration of the intact granules. Thus, in the presence of phosphate about 90% of the molecules behaved as colloids with Mr = 30,300 at c = o. After lysis in phosphate-free buffers the chromogranins behaved as highly non-ideal solutes in a manner which was incompatible with isotonicity at the protein concentration of the intact granules. About two-thirds of the molecules in the lysates in Na-succinate pH 5-6 and K-acetate pH 6 exhibited Mr = 66,000 and 79,000, respectively. In dilute solutions (less than 12 mg protein X ml-1) and ATP/protein ratios corresponding to those in the intact granules, the UM2 pressures were markedly increased, indicating release of polypeptides with Mr 2000-3000 from aggregates. CaCl2 was without specific effect on the colloid osmotic pressures but reduced the ATP-dependent increase in pressure, suggesting release of molecules twice the size of those released by ATP alone. A model is presented for the contribution of the chromogranins to osmotic pressure regulation in the bovine adrenomedullary catecholamine-storing granules.


Subject(s)
Catecholamines/metabolism , Chromaffin Granules/metabolism , Chromaffin System/metabolism , Chromogranins/physiology , Nerve Tissue Proteins/physiology , Adenosine Triphosphate/physiology , Animals , Calcium/physiology , Cattle , Hydrogen-Ion Concentration , Models, Chemical , Molecular Weight , Osmolar Concentration , Osmotic Pressure
10.
Int J Biochem ; 16(6): 641-50, 1984.
Article in English | MEDLINE | ID: mdl-6468729

ABSTRACT

Searching for endogenous proteolytic activities converting the membrane form of dopamine beta-hydroxylase (dopamine beta-monooxygenase, DBH) into the soluble and releasable form, DBH was monitored enzymatically and immunologically in aqueous and detergent-solubilized extracts of the adrenomedullary fractions. Degradation of the soluble DBH and acidic chromogranins by activation of endogenous proteases occurred during lysis in H2O. Shifts in the hydrophobicity of the membrane DBH were also apparent. Loss in enzyme protein or activity was, on the other hand, not observed for buffer-dialysed CG (pH 5-6). Limited proteolysis within the membrane phase was, however, indicated by the shift towards dominance of the intermediate hydrophobic DBH in the buffer-dialysed CG. By two-dimensional, crossed immunoelectrophoresis with cationic detergent the microsomal DBH was immunologically identical to the granule-bound enzyme but differed from the latter in molecular heterogeneity and in susceptibility to proteolytic solubilization by endogenous protease activities. DBH in the membranes of the chromaffin granules was proteolytically solubilized at pH 6-8 and the soluble DBH further degraded at pH 5. The results indicate that a post-translational conversion of the amphiphilic DBH into the soluble form, initiated at the level of the microsomes, may continue within the light and the heavy granule fractions which contain several DBH-converting and degrading proteolytic activities with acid optima.


Subject(s)
Adrenal Medulla/enzymology , Chromaffin Granules/enzymology , Chromaffin System/enzymology , Dopamine beta-Hydroxylase/isolation & purification , Enzyme Precursors/isolation & purification , Intracellular Membranes/enzymology , Animals , Cattle , Dopamine beta-Hydroxylase/metabolism , Enzyme Activation , Enzyme Precursors/metabolism , Immunoelectrophoresis, Two-Dimensional , Microsomes/enzymology , Protease Inhibitors/pharmacology
11.
Cell Tissue Res ; 231(2): 399-414, 1983.
Article in English | MEDLINE | ID: mdl-6850808

ABSTRACT

The general and ultrastructural organization of the heart of the elasmobranch, Scyllium stellare, was studied in normal and in anoxic animals. The rich coronary supply was revealed three-dimensionally by the use of corrosion casts, showing a thebesian system of coronary arterioles and capillaries in the thin, outer compact layer as well as in the predominant, inner spongy layer of trabeculae. Only the sinus venosus received a neuronal input of large bundles of granule-containing axons terminating at fenestrated regions of the endocardium and suggesting a neurohormonal function. A simple, tubular sarcoplasmic reticulum with flattened junctional cisternae was present in myocardial cells of 1-5 microns diameter, which contained one or two bundles of myofibrils. The latter were closely apposed to the inner aspect of the plasmalemma. Mitochondria were located centrally in the cells, which were joined by unfolded desmosomes involving Z-band material. Long periods of anoxia were tolerated without loss of heart function, but at the expense of cytoplasmic glycogen. Lipid granules were abundant in all layers and chambers, notably in animals prepared in the summer. The lipid granules displayed a marked increased in electron density when the heart was incubated in a buffered oxalate solution prior to fixation. A glycogen-sparing effect of the lipids during anoxia was observed.


Subject(s)
Fishes/anatomy & histology , Myocardium/ultrastructure , Animals , Female , Glycogen/metabolism , Hypoxia/metabolism , Hypoxia/pathology , Lipid Metabolism , Microscopy, Electron , Myocardium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...